Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Vijay U. Rao"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionThirty oral targeted antineoplastic agents are associated with prolongation of the QT interval. However, limited data exists regarding QTc prolongation and associated risk factors in the ambulatory oncology setting.MethodsThis retrospecti
Externí odkaz:
https://doaj.org/article/a722ae9ce2ef4d9e851fe49afafc8916
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Externí odkaz:
https://doaj.org/article/ef7a3a9f318840cb826a8d8ec2fba224
Autor:
Tracy Y. Wang, Lars G. Svensson, Jun Wen, Andrew Vekstein, Marc Gerdisch, Vijay U. Rao, Michael Moront, Doug Johnston, Renato D. Lopes, Alma Chavez, Marc Ruel, Eugene H. Blackstone, Richard C. Becker, Vinod Thourani, John Puskas, Hussein R. Al-Khalidi, David G. Cable, John A. Elefteriades, Alberto Pochettino, J. Alan Wolfe, Allen Graeve, Ibrahim Sultan, Ashraf A. Sabe, Hector I. Michelena, John H. Alexander
Publikováno v:
NEJM Evidence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4ce82090387a80a130331b29d3f2630
https://doi.org/10.1056/evidoa2300067
https://doi.org/10.1056/evidoa2300067
Publikováno v:
Hospital Practice. 50:170-182
Despite advancements in care for patients with heart failure (HF), morbidity and mortality remain high. Hospitalizations and readmissions for HF have been the focus of significant attention among health care providers and payers, with an eye toward r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f41d29309d3c681fb8533d004fb01e
https://doi.org/10.1080/21548331.2022.2082776
https://doi.org/10.1080/21548331.2022.2082776
Autor:
David Reeves, Ana Barac, Rupal O'Quinn, Michael G. Fradley, Vijay U. Rao, Susan Dent, Daniel J. Lenihan, Atul R. Chugh, Meghana Raghavendra
Publikováno v:
Journal of the American College of Cardiology. 77:2693-2716
Precision medicine has ushered in a new era of targeted treatments for numerous malignancies, leading to improvements in overall survival. Unlike traditional chemotherapy, many molecular targeted antineoplastic agents are available in oral formulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f48239afcf329235c251ca6111dcdfe
https://doi.org/10.1016/j.jacc.2021.04.009
https://doi.org/10.1016/j.jacc.2021.04.009
Autor:
David J. Reeves, Vijay U. Rao
Publikováno v:
Current opinion in cardiology. 37(4)
Recent advances in oncologic therapies have significantly improved overall survival for patients with malignancy. However, cardiovascular complications have not only increased in this population due to shared risk factors and pathophysiology, but als
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feeba0232812c6f682b35e695e2d37b7
https://pubmed.ncbi.nlm.nih.gov/35731682
https://pubmed.ncbi.nlm.nih.gov/35731682
Publikováno v:
Oncology Issues. 36:50-58
In the summer of 2016, Dr. Vijay Rao of Franciscan Physician Network Indiana Heart Physicians was alarmed when he realized that three patients he was treating for congestive heart failure had a his...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e8a82bbead54e9a9147a9accf969afb
https://doi.org/10.1080/10463356.2021.1901548
https://doi.org/10.1080/10463356.2021.1901548
Autor:
Vijay U, Rao, David J, Reeves, Atul R, Chugh, Rupal, O'Quinn, Michael G, Fradley, Meghana, Raghavendra, Susan, Dent, Ana, Barac, Daniel, Lenihan
Publikováno v:
Journal of the American College of Cardiology. 77(21)
Precision medicine has ushered in a new era of targeted treatments for numerous malignancies, leading to improvements in overall survival. Unlike traditional chemotherapy, many molecular targeted antineoplastic agents are available in oral formulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6904d8589d075539eb65c686c327eb47
https://pubmed.ncbi.nlm.nih.gov/34045027
https://pubmed.ncbi.nlm.nih.gov/34045027
Autor:
Roohi Ismail-Khan, Arjun K. Ghosh, Carolina Maria Pinto Domingues Carvalho Silva, Rupal O'Quinn, Sherry-Ann Brown, Jeanne M. DeCara, Leah Elson, Tochukwu M. Okwuosa, Anita Arnold, Lauren A. Baldassarre, Franck Thuny, Lavanya Kondapalli, Nausheen Akhter, Luis M. Raez, Zeina Nahleh, Joerg Herrmann, Monika Leja, Anne H. Blaes, Kerry Skurka, Daniel Sierra Lara, Brenton Bauer, Sebastian Szmit, Eric H. Yang, Andres Daniele, Husam Abdel-Qadir, Jayant Raikhelkar, Vijay U. Rao, Jorge Lax, Susan Dent, Diego Sadler, Rohit Moudgil, Vlad G. Zaha
BackgroundRe-allocation of resources during the COVID-19 pandemic has resulted in delays in care delivery to patients with cardiovascular disease and cancer. The ability of health care providers to provide optimal care in this setting has not been fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1ec3b8da6c3785fb588d195cb30cdf9
https://doi.org/10.21203/rs.3.rs-88776/v1
https://doi.org/10.21203/rs.3.rs-88776/v1
Autor:
Nan Wang, Vijay U. Rao, Brian R. Overholser, Kevin M. Sowinski, Jo E. Rodgers, Ahmed Aldemerdash, James E. Tisdale, Mark D. Fisch, Richard J. Kovacs, Elena Tomaselli Muensterman, Chia Chi Hsu, Heather A. Jaynes
Publikováno v:
J Card Fail
Background Patients with heart failure (HF) with reduced ejection fraction demonstrate enhanced response to drug-induced QT interval lengthening and are at increased risk for torsades de pointes. The influence of HF with preserved ejection fraction (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297367958e8f94051d0417112cd0085a
https://europepmc.org/articles/PMC7529874/
https://europepmc.org/articles/PMC7529874/